Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal-flow vs Low-flow Sevoflurane in RIRS
NCT07248917Completed
- Sponsor
- Kartal Dr. Lütfi Kırdar City Hospital
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sevoflurane in urolithiasis (2 arms), sponsored by Kartal Dr. Lütfi Kırdar City Hospital. Primary endpoint: Total Sevoflurane Consumption. Started Oct 2024; status: completed.
02
Drugs
sevoflurane
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT07248917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07248917.